t.abubakar
TL2 Moderator · Plovdiv
Contributes reviews on supplier material. Based in Plovdiv.
Joined 3 May 2025 · last posted 2d
75 posts, newest first. Showing up to 150.
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #90 · Meta › Announcements · 26 Jul 2026 · 26 likes RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for this subcategory.
-
Follow-up: Reading an interaction checker output critically Replied, post #66 · Practice › Interactions · 26 Jul 2026 · 0 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #43 · Access › Pricing · 17 Jul 2026 · 13 likes post #42 answers the question as asked. The question underneath it is different. Insurance tier placement: a compound might be covered but on a higher tier (higher…
-
What is genuinely unknown about long-term amylin agonism Replied, post #32 · Compounds › Cagrilintide & amylin analogues · 13 Jul 2026 · 0 likes post #31 answers the question as asked. The question underneath it is different. What is genuinely unknown about long-term amylin agonism: real-world response rates,…
-
The headache that turns out to be dehydration — the long version Replied, post #60 · Nutrition & Training › Hydration & electrolytes · 2 Jul 2026 · 0 likes post #59 answers the question as asked. The question underneath it is different. Magnesium: deficiency during weight loss is common and symptoms (fatigue, muscle…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #79 · Start Here › How to Ask · 28 Jun 2026 · 0 likes Worth separating two things that post #75 runs together. The specific question in the title is more useful than you might think. A title like "a question I have" forces…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #90 · Safety › Contraindications · 28 Jun 2026 · 25 likes Concurrent insulin or sulfonylureas: not an absolute contraindication but requires dose adjustment and close monitoring for hypoglycemia. The combination is used with…
-
Tracking intake honestly when appetite is absent Replied, post #75 · Nutrition & Training › Protein & intake · 27 Jun 2026 · 2 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #37 · Access › International · 26 Jun 2026 · 14 likes post #36 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #14 · Practice › Side effects · 25 Jun 2026 · 1 like Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #34 · Sourcing › Independent verification · 22 Jun 2026 · 0 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Documenting a supplier's response to a discrepancy Replied, post #18 · Sourcing › Vendor reports · 19 Jun 2026 · 29 likes Picking up post #15: that is the part I would want checked first. Multiple services on one lot: agreement across two independent laboratories is stronger than a high…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #80 · Compounds › Semaglutide · 17 Jun 2026 · 16 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #2 · marked as the solution · Practice › Side effects · 16 Jun 2026 · 19 likes On the opening post — agreed on the reasoning, with one qualification. Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #19 · Research Methods › Statistics · 10 Jun 2026 · 2 likes Worth separating two things that post #15 runs together. Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A difference…
-
Designing a personal experiment that could change your mind — one year on Replied, post #57 · Research Methods › N-of-1 designs · 7 Jun 2026 · 25 likes Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined number of measurements, or after a defined condition is met).…
-
Request: a per-category review queue Replied, post #18 · Meta › Feature requests · 4 Jun 2026 · 0 likes Coming back to post #16, because the follow-up matters more than the original answer. Requests for platform and documentation features, with the reasoning that…
-
Reading a trial's population section before its results Replied, post #79 · Evidence › Trials · 2 Jun 2026 · 10 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #109 · Compounds › Tirzepatide · 31 May 2026 · 13 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #44 · Practice › Storage & stability · 27 May 2026 · 22 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #51 · Devices › Syringes & needles · 25 May 2026 · 10 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
Reading a trial's population section before its results Replied, post #8 · marked as the solution · Evidence › Trials · 9 May 2026 · 12 likes Worth separating two things that post #4 runs together. The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #47 · Clinical › Bloodwork · 23 Apr 2026 · 0 likes Worth separating two things that post #43 runs together. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening.…
-
Journal club: is percentage weight change the right endpoint? Replied, post #36 · Evidence › Journal club · 3 Apr 2026 · 1 like I read post #34 twice before replying, because I had assumed the opposite. Session format: read the paper before posting. The discussion is much better when everyone…
-
Coming back to: Time to steady state after a dose increase Replied, post #24 · Pharmacology › Pharmacokinetics · 1 Apr 2026 · 5 likes This follows post #21 rather than contradicting it. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #82 · Practice › Dosing & titration · 29 Mar 2026 · 5 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
-
Choosing which test to pay for, given a fixed budget Replied, post #24 · Sourcing › Independent verification · 14 Mar 2026 · 7 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #53 · Compounds › Repair & healing peptides · 13 Mar 2026 · 0 likes post #52 is right about the mechanism and I think understates the practical bit. The distinction between "no evidence it works" and "evidence it does not work": we have…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #58 · Analytics › Mass spectrometry · 5 Mar 2026 · 31 likes Picking up post #55: that is the part I would want checked first. Desalting before analysis: some samples need desalting to remove salts that suppress the peptide…
-
Named, unnamed and unspecified impurities as regulatory categories Replied, post #8 · Analytics › Impurities & related substances · 28 Feb 2026 · 0 likes Worth separating two things that post #4 runs together. Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically…
-
Validating a calculator against hand arithmetic Replied, post #8 · Data & Tools › Calculators · 26 Feb 2026 · 7 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #74 · Sourcing › Vendor reports · 25 Feb 2026 · 28 likes Coming back to post #72, because the follow-up matters more than the original answer. What "verified" means on our pages: specific lots were independently measured on…
-
Measurement error in a self-reported exposure Replied, post #30 · Evidence › Study critique · 23 Feb 2026 · 10 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #101 · Compounds › Oral incretins · 17 Feb 2026 · 4 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
A history of disordered eating: proceeding carefully Replied, post #71 · Wellbeing › Mental health · 23 Jan 2026 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
The headache that turns out to be dehydration Replied, post #142 · Nutrition & Training › Hydration & electrolytes · 17 Jan 2026 · 2 likes Water intoxication: drinking excessive water (more than a few liters per day for extended time) without electrolyte replacement can cause hyponatremia. This is rare but…
-
A partial dose because the pen emptied mid-injection Replied, post #12 · Practice › Administration · 7 Jan 2026 · 2 likes On post #8 — agreed on the reasoning, with one qualification. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated…
-
Prescription requirements and telehealth models Replied, post #46 · Sourcing › Regulatory · 3 Dec 2025 · 4 likes Picking up post #43: that is the part I would want checked first. Approval versus licensing: a compound can be approved for a specific indication in one country and not…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #89 · Practice › Reconstitution · 26 Nov 2025 · 0 likes Worth separating two things that post #85 runs together. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and…
-
New subcategory: rationale and scope Replied, post #19 · Meta › Announcements · 14 Oct 2025 · 0 likes On post #15 — agreed on the reasoning, with one qualification. RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #82 · Practice › Storage & stability · 4 Oct 2025 · 11 likes On post #78 — agreed on the reasoning, with one qualification. Temperature excursions: if a vial sat at room temperature for a time, the question is whether the…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #105 · Evidence › Preprints · 3 Oct 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Reading a supplier's product description as a marketing document Replied, post #74 · Compounds › Other compounds · 23 Sep 2025 · 24 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Titles that describe the question, not the situation Replied, post #72 · Start Here › How to Ask · 15 Aug 2025 · 21 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
Guidelines revision: what changed and why — one year on Replied, post #6 · Meta › Announcements · 8 Aug 2025 · 3 likes RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for this subcategory.
-
A preprint whose numbers changed substantially at publication Replied, post #11 · Evidence › Preprints · 6 Aug 2025 · 18 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #7 · Compounds › Other compounds · 5 Aug 2025 · 19 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #22 · Compounds › Repair & healing peptides · 23 Jul 2025 · 8 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #36 · Analytics › Home & field testing · 9 Jul 2025 · 0 likes post #35 is right about the mechanism and I think understates the practical bit. Sample handling matters: if a sample is contaminated or degraded before testing, the…
-
Holding a dose indefinitely: is there a documented downside? Replied, post #27 · Practice › Dosing & titration · 23 Jun 2025 · 0 likes post #26 answers the question as asked. The question underneath it is different. Steady state means the plasma concentration is stable from dose to dose. That happens…
-
Coming back to: Official shortage notices and what they authorise Replied, post #27 · Access › Shortages · 11 Jun 2025 · 16 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
-
Anxiety in the first weeks: drug, situation, or both Replied, post #100 · Wellbeing › Mental health · 9 Jun 2025 · 6 likes post #99 is right about the mechanism and I think understates the practical bit. Body image and weight loss: large weight loss changes a person's relationship with…
-
Pre-registering a personal experiment, seriously Replied, post #78 · Research Methods › N-of-1 designs · 1 Jun 2025 · 1 like Coming back to post #76, because the follow-up matters more than the original answer. Sample size in n-of-1: you are the sample. Repeated measurements (weekly…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #59 · Data & Tools › Calculators · 9 May 2025 · 8 likes Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #51 · Compounds › Tirzepatide · 8 May 2025 · 0 likes Picking up post #48: that is the part I would want checked first. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that…
-
Washout: how long is long enough, and for what purpose Replied, post #20 · Pharmacology › Pharmacokinetics · 23 Apr 2025 · 0 likes Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #70 · Evidence › Journal club · 20 Apr 2025 · 11 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
[2026 update] US compounding rules and how they changed Replied, post #7 · Regional › North America · 7 Apr 2025 · 5 likes Coming back to post #5, because the follow-up matters more than the original answer. Cross-border purchase: buying in the US and bringing to Canada or vice versa…
-
Reading a supplier's product description as a marketing document Replied, post #10 · Compounds › Other compounds · 5 Apr 2025 · 9 likes I read post #8 twice before replying, because I had assumed the opposite. This subcategory exists because some people will research compounds outside the main groups…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #76 · Analytics › COA interpretation · 13 Mar 2025 · 18 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Second pass at: A single out-of-range value on an otherwise normal panel Replied, post #10 · Clinical › Bloodwork · 12 Mar 2025 · 0 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Distinguishing a deletion sequence by mass alone Replied, post #94 · Analytics › Mass spectrometry · 16 Feb 2025 · 1 like Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
Books and papers worth reading that are not about this at all Replied, post #17 · Lounge › Off topic · 9 Jan 2025 · 5 likes Coming back to post #15, because the follow-up matters more than the original answer. Lower-stakes conversation that does not belong in the technical categories. Still…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #100 · Compounds › Oral incretins · 28 Dec 2024 · 24 likes PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
-
Building a sensible monitoring schedule with your prescriber Replied, post #45 · Clinical › Bloodwork · 20 Dec 2024 · 8 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] How to read a forest plot, properly, from scratch Replied, post #19 · Evidence › Trials · 6 Dec 2024 · 2 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
-
[2026 update] New subcategory: rationale and scope Replied, post #26 · Meta › Announcements · 27 Nov 2024 · 12 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #16 · Sourcing › Regulatory · 25 Oct 2024 · 0 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
-
Requesting a page: what makes a good request — what changed since Replied, post #36 · Documentation › Wiki requests · 10 Oct 2024 · 4 likes post #35 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #53 · Clinical › Bloodwork · 24 Sep 2024 · 1 like post #52 is right about the mechanism and I think understates the practical bit. Biological variation: the person-to-person variation in a biomarker for a healthy…
-
Progressive overload when the scale is falling — one year on Replied, post #72 · Nutrition & Training › Resistance training · 20 Sep 2024 · 0 likes Intensity: using weights that allow 6 to 12 reps before fatigue is a reasonable range for preserving muscle. Heavier weights with lower reps can work but require more…
-
About the Retatrutide category Replied, post #4 · Compounds › Retatrutide · 10 Aug 2024 · 12 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Guidelines revision: what changed and why Replied, post #7 · Meta › Announcements · 24 Jul 2024 · 0 likes Coming back to post #5, because the follow-up matters more than the original answer. Staff announcements, policy changes, and scheduled maintenance. Read-only except…
-
Cold packs, phase-change material, and what survives ten days Replied, post #15 · Sourcing › Logistics · 15 Jun 2024 · 22 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #12 · Practice › Dosing & titration · 12 Jun 2024 · 32 likes On post #8 — agreed on the reasoning, with one qualification. Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials…